Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$0.66

+0.02 (+3.36%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +5,823.2% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $0.66

Current
$0.66

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

3,284.0%

Low target

Base Case

$39.33

+5,823.2%

Avg target

Bull Case

$48.65

+7,226.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$3.09

-78.5% from high

52-Week Low

$0.48

+38.3% from low

Target vs 52W High

$39.33

+1,172.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%